Models of care in custodial settings

Prison populations in Australia have a high prevalence of HCV infection, estimated at 30%, 12 which reflects the close relationship between injecting drug use, HCV infection and incarceration. Although treatment uptake in custodial settings across Australia remains extremely low, incarceration presents a unique opportunity for HCV therapy due to improved direct access to health care and stable accommodation. Both Australian and international studies have demonstrated the safety, feasibility and acceptability of nurse-led models of IFN-based HCV treatment in prison populations, 7,13,14 supported by specialist teleconferencing. With newer DAA regimens, the ease of treatment will be considerably enhanced in this breast list setting. Treatment of prisoners is a priority to reduce the incidence of HCV transmission

Tags: CCK